| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BLDE | Class A common stock, $0.0001 par value per share | Sale | $5,212 | -1,750 | -1.3% | $2.98 | 134,232 | 05 Apr 2023 | Direct | F1, F2 |
| transaction | BLDE | Class A common stock, $0.0001 par value per share | Sale | $3,930 | -1,348 | -1% | $2.92 | 132,884 | 06 Apr 2023 | Direct | F1, F3 |
| transaction | BLDE | Class A common stock, $0.0001 par value per share | Sale | $7,523 | -2,655 | -2% | $2.83 | 130,229 | 10 Apr 2023 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.825 to $3.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.87 to $3.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.805 to $2.935, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
The sales reported on this Form 4 were effected pursuant to a contract, instruction or written plan adopted prior to February 27, 2023 that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) as in effect on the date of adoption.